OpenAI has announced that it is conducting internal testing on its latest reasoning AI models, named “o3” and “o3 mini,” as part of its effort to develop more advanced artificial intelligence systems capable of addressing complex tasks. The company plans to release the o3 mini model by the end of January 2025, with the full version of the o3 model following soon after. The announcement follows the launch of OpenAI’s o1 models in September 2024, designed for deeper reasoning and problem-solving across domains such as science, mathematics, and coding.

Pudu Robotics has launched its first full-sized bipedal humanoid robot, the PUDU D9. Developed by the Pudu X-Lab, the PUDU D9 is the third product introduced by the team in 2024, following the semi-humanoid robot PUDU D7 and the PUDU DH11 dexterous robotic hand. The robot is designed to advance commercially viable embodied intelligence and is expected to be available for pre-sale soon.

Realbotix, a developer of humanoid robots and companionship-based artificial intelligence, has outlined its business plans for 2025, with a focus on AI and robotics advancements, cryptocurrency strategies, and market presence expansion. The company noted a transformative 2024 that included a corporate rebranding and deeper engagement in AI and robotics. CEO Andrew Kiguel highlighted the firm’s confidence in the potential of its initiatives to generate shareholder value in 2025, emphasizing both its cryptocurrency holdings and product development.

In a milestone for the robotics industry, Figure, specializing in humanoid robots, announced it has officially become a revenue-generating entity. The news was shared by Brett Adcock, Founder of Figure, on social media, marking an important step in its journey to commercial viability.

A research and development initiative, supported by Defra and Innovate UK, seeks to help sustainable tomato cultivation through AI-driven monitoring technology. The project, “TomatoGuard: Advanced AI-Driven Pest and Stress Detection for Sustainable Tomato Cultivation,” focuses on early detection and management of crop stress to improve efficiency and reduce environmental impact.

In a newly released video, Palantir Technologies showcases its vision for the future of warfare. The company is among several tech firms testing their technologies in real-world conflict zones, including Ukraine. This video shows Palantir Gotham, a data integration and analytics platform designed to help organizations make informed decisions by consolidating, analyzing, and visualizing complex data. Gotham was specifically developed for use by government and defense organizations.

NASA is set to enhance its lunar exploration efforts by deploying an array of robotic instruments to the Moon’s surface as part of its partnership with Firefly Aerospace. This initiative, under NASA’s Commercial Lunar Payload Services (CLPS) program, involves a $179 million contract for Firefly to deliver six science experiments and technology demonstrations to the Gruithuisen Domes, a geological formation on the Moon’s near side, by 2028.

Osaka Metropolitan University researchers have developed an automated system that leverages robotics to improve rehabilitation outcomes for patients with upper extremity paralysis caused by stroke. The system, based on data collected through the use of Teijin Pharma Ltd.’s rehabilitation robot ReoGo-J, aims to optimize care by recommending tailored rehabilitation programs aligned with the severity of motor paralysis.

NVIDIA has introduced the Jetson Orin Nano Super Developer Kit, a compact generative AI supercomputer designed to enhance accessibility and performance for developers, hobbyists, and students. Priced at $249—significantly lower than its predecessor’s $499—the device offers notable advancements in generative AI capabilities.

University Hospitals (UH) Cleveland Medical Center has become the first health system in Northeast Ohio to adopt the Da Vinci 5 (DV5) Surgical Robot for robotic-assisted surgeries. This advanced system introduces enhancements designed to improve surgical precision, patient outcomes, and operational efficiency. Twenty-six surgeons at UH Cleveland Medical Center are trained to perform a range of procedures using the DV5, including esophagectomies and gastric bypasses.